In the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study, in which alanine amino transferase (ALT) was used as a surrogate measure of NAFLD, multiple linear regression analysis was used to investigate the association between ALT and several metabolic syndrome components as potential mediators of the liver disease. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.